• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾素-血管紧张素系统与心脏:2000年以后

The renin-angiotensin system and the heart: beyond 2000.

作者信息

Morgan T, Brunner H R

机构信息

Department of Physiology, University of Melbourne, Parkville, Australia.

出版信息

Heart. 1996 Nov;76(3 Suppl 3):98-103. doi: 10.1136/hrt.76.3_suppl_3.98.

DOI:10.1136/hrt.76.3_suppl_3.98
PMID:8983669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC484496/
Abstract

Renin-angiotensin is both a circulatory and a local tissue system. However, in most circumstances, renin present in the heart and blood vessels is taken up from the plasma, and the kidney is the prime source of this renin. Tissues can then modulate and control the production of angiotensin II. In various organs, angiotensin II has local actions. In the heart, working through the AT1 receptor, it increases contractility and may cause cardiocyte hypertrophy. Indirectly, the heart is also very much affected by the vascular actions of angiotensin II. However, the net result on the heart is the product of an important interaction between a large number of factors. There is little doubt that an inappropriately high plasma (and tissue) level of renin, related to sodium balance, is associated with increased left ventricular hypertrophy and cardiovascular complications. The genetic approach will lead to an understanding of genomic risk factors in hypertension and may identify control systems--at present unknown--which will lead to a new approach to the prevention of cardiovascular death. It is, however, unlikely that such a factor will clearly predict an individual's prognosis, but it will, rather, identify groups at risk. Constellations of genomic interactions with multiple environment factors reduce this power. Modification of the response to angiotensin II using present treatment, or interrupting the response at more distal sites, may enable us to achieve the beneficial effects on cardiac hypertrophy without the detrimental effects.

摘要

肾素-血管紧张素既是一种循环系统,也是一种局部组织系统。然而,在大多数情况下,心脏和血管中的肾素是从血浆中摄取的,而肾脏是这种肾素的主要来源。组织随后可以调节和控制血管紧张素II的产生。在各种器官中,血管紧张素II具有局部作用。在心脏中,通过AT1受体起作用,它可增加心肌收缩力并可能导致心肌细胞肥大。间接而言,心脏也会受到血管紧张素II血管作用的很大影响。然而,对心脏的最终影响是大量因素之间重要相互作用的结果。毫无疑问,与钠平衡相关的肾素血浆(和组织)水平过高会导致左心室肥厚和心血管并发症增加。遗传学方法将有助于了解高血压中的基因组危险因素,并可能识别目前未知的控制系统,这将带来预防心血管死亡的新方法。然而,这样一个因素不太可能明确预测个体的预后,而是会识别出有风险的群体。基因组与多种环境因素的相互作用组合会降低这种预测能力。使用现有治疗方法改变对血管紧张素II的反应,或在更远端部位阻断反应,可能使我们在不产生有害影响的情况下实现对心肌肥厚的有益作用。

相似文献

1
The renin-angiotensin system and the heart: beyond 2000.肾素-血管紧张素系统与心脏:2000年以后
Heart. 1996 Nov;76(3 Suppl 3):98-103. doi: 10.1136/hrt.76.3_suppl_3.98.
2
[The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].[血管紧张素II受体选择性阻断在心血管疾病治疗中的作用]
Clin Ter. 2001 Mar-Apr;152(2):103-6.
3
Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.心脏和血管系统中的组织肾素-血管紧张素系统:可能参与血管紧张素转换酶抑制剂的心血管作用。
Am J Cardiol. 1990 May 22;65(19):3I-10I. doi: 10.1016/0002-9149(90)90118-k.
4
Myocardial hypertrophy, angiotensin, and ACE inhibitors.
Angiology. 1993 Nov;44(11):875-81. doi: 10.1177/000331979304401105.
5
[Left-ventricular hypertrophy as a cardiac risk factor: role of the renin-angiotensin-aldosterone system].左心室肥厚作为一种心脏危险因素:肾素-血管紧张素-醛固酮系统的作用
Praxis (Bern 1994). 1996 Feb 20;85(8):227-33.
6
Angiotensin II receptor blockade and end-organ protection: pharmacological rationale and evidence.血管紧张素II受体阻断与靶器官保护:药理学原理与证据
J Hypertens Suppl. 1998 Sep;16(7):S3-9.
7
Is there an internal cardiac renin-angiotensin system?心脏内部存在肾素-血管紧张素系统吗?
Heart. 1996 Nov;76(3 Suppl 3):28-32. doi: 10.1136/hrt.76.3_suppl_3.28.
8
Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease.血管紧张素II是心血管疾病独立危险因素的实验和临床证据。
Am J Cardiol. 2001 Apr 19;87(8A):3C-9C. doi: 10.1016/s0002-9149(01)01538-7.
9
[Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].[血管紧张素II对心脏的生长刺激特性:对心力衰竭治疗的影响]
Z Kardiol. 1993;82 Suppl 4:1-6.
10
[Role of the cardiac renin-angiotensin system in hypertensive heart disease].心脏肾素-血管紧张素系统在高血压性心脏病中的作用
Herz. 1995 Oct;20(5):322-9.

引用本文的文献

1
Matters of the heart transcriptome: a brief history of cardiovascular genomics.心脏转录组相关事宜:心血管基因组学简史
Tex Heart Inst J. 2002;29(2):81-91.

本文引用的文献

1
Is there an internal cardiac renin-angiotensin system?心脏内部存在肾素-血管紧张素系统吗?
Heart. 1996 Nov;76(3 Suppl 3):28-32. doi: 10.1136/hrt.76.3_suppl_3.28.
2
The renin-angiotensin system and cardiac hypertrophy.肾素-血管紧张素系统与心肌肥厚。
Heart. 1996 Nov;76(3 Suppl 3):33-5. doi: 10.1136/hrt.76.3_suppl_3.33.
3
Cardiovascular disease and genetics of the renin-angiotensin system.心血管疾病与肾素-血管紧张素系统的遗传学
Heart. 1996 Nov;76(3 Suppl 3):13-7. doi: 10.1136/hrt.76.3_suppl_3.13.
4
The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.肾素-血管紧张素系统与容量超负荷诱导的大鼠心肌肥厚。血管紧张素转换酶抑制剂与血管紧张素II受体阻滞剂的作用
Circulation. 1993 Mar;87(3):921-30. doi: 10.1161/01.cir.87.3.921.
5
Vascular biology and medicine in the 1990s: scope, concepts, potentials, and perspectives.20世纪90年代的血管生物学与医学:范围、概念、潜力及展望。
Circulation. 1993 Mar;87(3):705-19. doi: 10.1161/01.cir.87.3.705.
6
Nephrectomy, converting enzyme inhibition, and angiotensin peptides.肾切除术、转换酶抑制与血管紧张素肽
Hypertension. 1993 Oct;22(4):513-22. doi: 10.1161/01.hyp.22.4.513.
7
Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence.肾素并非由心脏和肾外血管组织合成。实验证据综述。
Circulation. 1994 Jan;89(1):458-70. doi: 10.1161/01.cir.89.1.458.
8
Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.血管紧张素转换酶抑制可改善心脏功能。缓激肽的作用。
Hypertension. 1994 Apr;23(4):411-8. doi: 10.1161/01.hyp.23.4.411.
9
Glucocorticoid-remediable aldosteronism.糖皮质激素可治性醛固酮增多症
Endocrinol Metab Clin North Am. 1994 Jun;23(2):285-97.
10
Effects of enalapril and Dup753 on renin synthesis in mice with one hydronephrotic kidney.
Clin Exp Pharmacol Physiol. 1994 Feb;21(2):133-5. doi: 10.1111/j.1440-1681.1994.tb02481.x.